ESTIMATION OF CORONARY FLOW RESERVE BY TRANSESOPHAGEAL CORONARY SINUS DOPPLER MEASUREMENTS IN PATIENTS WITH SYNDROME-X AND PATIENTS WITH SIGNIFICANT LEFT CORONARY-ARTERY DISEASE

Objectives. This study sought to determine the feasibility of coronary sinus how velocity analysis by transesophageal Doppler echocardiography for estimation of coronary flow reserve in patients with syndrome X and patients with coronary artery disease. Background. Coronary flow reserve provides useful information in patients with coronary artery disease and patients with syn drome X. Current methods of measuring coronary flow reserve are invasive or require extensive laboratory equipment, or both. Transesophageal Doppler recordings of coronary sinus flow velocity before and after vasodilator application may allow noninvasive determination of coronary flow reserve. Methods. We obtained coronary sinus flow velocity recordings before and after dipyridamole administration (0.6 mg/kg body weight per 5 min) in 9 patients with syndrome X, 14 with significant left coronary artery disease and 22 age-matched control patients. We used the formula anterograde minus retrograde how velocity time integral times heart rate as an index of coronary sinus flow. Coronary flow reserve was calculated by dividing coronary sinus flow variables after dipyridamole administration by the respective baseline values. Results. Technically adequate recordings were obtained in 44 (98%) of 45 patients. Compared with that in the control group (2.78 +/- 0.95 [mean +/- SD]), coronary flow reserve was significantly lower in patients with syndrome X (1.21 +/- 0.23, p less than or equal to 0.001) as well as in those with coronary artery disease (1.47 +/- 0.7, p less than or equal to 0.001). Using a cutoff coronary how reserve value of 1.8, sensitivity, specificity and overall predictive value of coronary flow reserve determinations were, respectively, 100%, 91% and 94% for syndrome X and 86%, 91% and 89% for coronary artery disease. Conclusions. Coronary how reserve calculation by transesophageal coronary sinus how velocity recordings is feasible in a large proportion of patients and might be useful for the noninvasive evaluation of patients with syndrome X and patients with severe left coronary artery disease.